Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination DMARDs vs Sulfasalazine Monotherapy in Early Seronegative Spondyloarthropathy
NCT01040195Phase 3Completed
- Sponsor
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Start
- Jun 2009
- Primary completion
- Nov 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate, hydroxychloroquine in spondyloarthritis (SpA), sponsored by Sanjay Gandhi Postgraduate Institute of Medical Sciences. Started Jun 2009; status: completed.
02
Drugs
methotrexatehydroxychloroquine
03
Conditions
spondyloarthritis (SpA)
Beyond the preview
Go deeper on NCT01040195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01040195.